Seeing Is Believing
VRCA is currently covered by 5 analysts with an average price target of $12.01. This is a potential upside of $6.44 (115.62%) from yesterday's end of day stock price of $5.57.
Verrica Pharmaceuticals's activity chart (see below) currently has 49 price targets and 56 ratings on display. The stock rating distribution of VRCA is 59.09% BUY and 40.91% HOLD.
Analysts average stock forecasts to be materialized ratio is 15.99% with an average time for these price targets to be met of 88.43 days.
Highest price target for VRCA is $3, Lowest price target is $2, average price target is $2.5.
Most recent stock forecast was given by SERGE BELANGER from NEEDHAM on 14-May-2025. First documented stock forecast 21-Feb-2019.
Currently out of the existing stock ratings of VRCA, 13 are a BUY (59.09%), 9 are a HOLD (40.91%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2 months 22 days ago
(14-May-2025)
3/9 (33.33%)
$9.09 (312.37%)
169
Hold
3 months 28 days ago
(08-Apr-2025)
0/13 (0%)
$4.51 (47.52%)
Buy
$3
$-2.63 (-46.71%)
$12
6 months 30 days ago
(06-Jan-2025)
1/4 (25%)
$2.33 (347.76%)
200
Hold
$2
$-3.63 (-64.48%)
9 months ago
(05-Nov-2024)
2/7 (28.57%)
$1.2 (150.00%)
171
Hold
$20
10 months 3 days ago
(02-Oct-2024)
0/1 (0%)
$12.04 (151.26%)
What is VRCA (Verrica Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on VRCA (Verrica Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on VRCA (Verrica Pharmaceuticals)?
Which analyst is the currently most bullish on VRCA (Verrica Pharmaceuticals)?
Which analyst is the currently most reserved on VRCA (Verrica Pharmaceuticals)?